[{"id":"ea4a5d4d-7485-48e5-9caf-f1b9a939013f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04444427","created_at":"2021-01-18T21:23:07.457Z","updated_at":"2024-07-02T16:35:58.581Z","phase":"Phase 1b/2","brief_title":"Evaluation of GLR2007 for Advanced Solid Tumors","source_id_and_acronym":"NCT04444427","lead_sponsor":"Gan and Lee Pharmaceuticals, USA","biomarkers":" EGFR • BRAF • ALK • ROS1 • NTRK1 • NTRK","pipe":"","alterations":" ","tags":["EGFR • BRAF • ALK • ROS1 • NTRK1 • NTRK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GLR2007"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 07/15/2020","start_date":" 07/15/2020","primary_txt":" Primary completion: 07/29/2022","primary_completion_date":" 07/29/2022","study_txt":" Completion: 07/29/2022","study_completion_date":" 07/29/2022","last_update_posted":"2022-12-23"}]